NCT03418142

Brief Summary

The trial aims to evaluate the effectiveness of a novel internet intervention (Priovi), which was designed to introduce relevant schema therapy techniques to Persons with Borderline Personality Disorder (BPD). Therefore, 200 people with BPD will be recruited and randomized to two groups: (1) a control group, in which they may engage with any BPD treatment (Care-as-Usual, CAU) and receive access to Priovi after a delay of 12 months (i.e., CAU/wait list control group), or (2) to a treatment group that immediately receives 12-month access to Priovi and may also use CAU. The primary outcome measure is the score of the Borderline Personality Disorder Severity Index (BPDSI), collected at three, six and 12 month post-baseline.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
206

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 23, 2018

Completed
6 days until next milestone

Study Start

First participant enrolled

January 29, 2018

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 1, 2018

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 29, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 29, 2020

Completed
Last Updated

February 24, 2020

Status Verified

February 1, 2020

Enrollment Period

2 years

First QC Date

January 23, 2018

Last Update Submit

February 21, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Score of the Borderline Personality Disorder Severity Index (BPDSI) - The BPDSI is a semi-structured interview assessing the frequency and severity of manifestations of borderline personality disorder (BPD) during the last three months.

    Semi-structured interview assessing BPD symptom frequency and severity

    Changes from baseline to 3, 6 and 12 months

Secondary Outcomes (6)

  • Severity of depressive symptoms, measured by Patient Health Questionnaire - 9 items (PHQ-9)

    Changes from baseline to 3, 6, 9 and 12 months.

  • GAD-7 (Generalized Anxiety Disorder Questionnaire)

    Changes from baseline to 3, 6, 9 and 12 months.

  • EQ-5D (standardized instrument developed by the EuroQol Group as a measure of health-related quality of life.)

    Changes from baseline to 3, 6, 9 and 12 months.

  • BPD-Checklist short (Borderline personality Disorder Checklist short)

    Changes from baseline to 3, 6, 9 and 12 months.

  • 2 Items of CIUS-Long-brief (Compulsive Internet Use Scale)

    Assessed at 3, 6, 9 and 12 months.

  • +1 more secondary outcomes

Study Arms (2)

Priovi

EXPERIMENTAL

Priovi is an Internet-administered intervention for people with BPD.

Behavioral: PrioviOther: CAU

Care-as-Usual (CAU) / wait list

ACTIVE COMPARATOR

Additionaly, they will be informed about helpful and free available online self-help-proposals for BPD patients immediately after randomization.

Other: CAU

Interventions

PrioviBEHAVIORAL

Priovi is an Internet intervention for people with BPD. Content is continuously adapted to patients' concerns and needs. Priovi is a comprehensive program, which is conceptually and substantially based on the schema therapeutic approach used in BPD patients. It contains interactive dialogues that can be accessed via computer or smartphone, illustrations, audios and motivating text messages. Techniques to cope with borderline symptoms (e.g., psychoeducation about modes, schemas and basic emotional needs in addition to relevant strategies to weaken, reduce and/or heal maladaptive schemas and modes) are conveyed in interactive sequences that are accompanied by audio recordings, illustrations, and worksheets. Patients are also prompted to regularly complete brief symptom severity self-monitoring questionnaires. Optional daily text messages with motivational content accompany the program. The program can be accessed for 365 days after registration.

Priovi
CAUOTHER

Care as Usual: In the CAU/wait list control group, participants are free to continue to engage with any treatment they require (i.e., CAU). However, they will receive access to Priovi after 12 months post-baseline (i.e., wait list with respect to Priovi access).

Care-as-Usual (CAU) / wait listPriovi

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Psychiatric diagnosis of BPD
  • BPDSI score of 15 or higher
  • Informed consent
  • German language proficiency
  • Willingness to participate in diagnostic and follow-up assessments as well as to see a -
  • Psychiatrist for validation of diagnosis
  • years or older

You may not qualify if:

  • Psychotic disorder
  • Primary psychiatric diagnosis of an addictive disorder
  • Schizotypal personality disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gaia AG

Hamburg, 20144, Germany

Location

Related Publications (3)

  • Klein JP, Hauer-von Mauschwitz A, Berger T, Fassbinder E, Mayer J, Borgwardt S, Wellhofer B, Schweiger U, Jacob G. Effectiveness and safety of the adjunctive use of an internet-based self-management intervention for borderline personality disorder in addition to care as usual: results from a randomised controlled trial. BMJ Open. 2021 Sep 8;11(9):e047771. doi: 10.1136/bmjopen-2020-047771.

  • Storebo OJ, Stoffers-Winterling JM, Vollm BA, Kongerslev MT, Mattivi JT, Jorgensen MS, Faltinsen E, Todorovac A, Sales CP, Callesen HE, Lieb K, Simonsen E. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2020 May 4;5(5):CD012955. doi: 10.1002/14651858.CD012955.pub2.

  • Klein JP, Hauer A, Berger T, Fassbinder E, Schweiger U, Jacob G. Protocol for the REVISIT-BPD Trial, a Randomized Controlled Trial Testing the Effectiveness of an Internet-Based Self-Management Intervention in the Treatment of Borderline Personality Disorder (BPD). Front Psychiatry. 2018 Sep 21;9:439. doi: 10.3389/fpsyt.2018.00439. eCollection 2018.

MeSH Terms

Conditions

Borderline Personality Disorder

Condition Hierarchy (Ancestors)

Personality DisordersMental Disorders

Study Officials

  • Jan Philipp Klein, Dr. med.

    University of Lübeck, Zentrum für Integrative Psychiatrie ZiP gGmbH

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 23, 2018

First Posted

February 1, 2018

Study Start

January 29, 2018

Primary Completion

January 29, 2020

Study Completion

January 29, 2020

Last Updated

February 24, 2020

Record last verified: 2020-02

Data Sharing

IPD Sharing
Will share

Anonymized individual participant data shall be made available upon request for projects such as meta-analyses after completion of the study

Locations